C12N 2502/11
Blood or immune system cells
Official title: blood or immune system cells
C12N2502/11 (Blood or immune system cells) appears on 746 US grants and 1,498 published applications in this corpus.
Search patents in C12N- Granted patents
- 746
- Published applications
- 1,498
- Assignees
- 658
- Inventors
- 2,233
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 2 | 0 |
| 2001 | 7 | 2 |
| 2002 | 4 | 6 |
| 2003 | 5 | 10 |
| 2004 | 0 | 8 |
| 2005 | 4 | 8 |
| 2006 | 1 | 15 |
| 2007 | 3 | 15 |
| 2008 | 3 | 12 |
| 2009 | 4 | 26 |
| 2010 | 13 | 26 |
| 2011 | 12 | 30 |
| 2012 | 14 | 33 |
| 2013 | 12 | 26 |
| 2014 | 18 | 37 |
| 2015 | 18 | 48 |
| 2016 | 21 | 53 |
| 2017 | 30 | 76 |
| 2018 | 63 | 95 |
| 2019 | 62 | 113 |
| 2020 | 35 | 104 |
| 2021 | 77 | 149 |
| 2022 | 64 | 170 |
| 2023 | 46 | 137 |
| 2024 | 76 | 131 |
| 2025 | 72 | 100 |
| 2026 | 46 | 68 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2502/1121Dendritic cellsIndexing code141
- C12N 2502/1114T cellsIndexing code131
- C12N 2502/1157Monocytes, macrophagesIndexing code86
- C12N 2502/115Platelets, megakaryocytesIndexing code45
- C12N 2502/1107B cellsIndexing code40
- C12N 2502/1171Haematopoietic stem cellsIndexing code19
- C12N 2502/1192Lymphatic cellsIndexing code19
- C12N 2502/1164Nk cellsIndexing code11
Recent patents
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Process for manufacturing of antigen-specific T lymphocytes8 Sep 2026US 12,729,369 B2Gdanski Uniwersytet Medyczny
- Methods for reducing elevated glucose levels11 Aug 2026US 12,703,856 B2SDF BioPharma Inc.
- Method for transduction of t cells in the presence of malignant cells4 Aug 2026US 12,698,315 B2Miltenyi Biotec GmbH
- B-cell cultivation method4 Aug 2026US 12,698,474 B2Hoffmann-La Roche Inc.
- Chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy8 Oct 2026US 2026/0308537 A1The Scripps Research Institute
- Method for culturing cord blood-derived natural killer cells using transformed t-cells1 Oct 2026US 2026/0297526 A1GC Cell Corporation
- Cancer models1 Oct 2026US 2026/0297534 A1Carcinotech Ltd
- Single b-cell cultivation method24 Sep 2026US 2026/0285949 A1Hoffmann-La Roche Inc.
- Systems and methods for cell culturing24 Sep 2026US 2026/0286267 A1Flaskworks, LLC
Most cited
By later US patents
- Chimeric receptors with 4-1BB stimulatory signaling domain329US 8,399,645 B2St. Jude Children?S Research Hospital · 2013
- Process for making human antibody producing B-lymphocytes323US 4,444,887 ASloan-Kettering Institute · 1984
- Process for producing human antibodies246US 4,716,111 ATrustees of Boston University · 1987
- Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use242US 5,192,553 ABiocyte Corporation · 1993
- High efficiency transduction of T lymphocytes using rapid expansion methods ("REM")235US 6,040,177 AFred Hutchinson Cancer Research Center · 2000